NCT01660217 Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management Status COMPLETED Phase NA
NCT01639040 Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT01638234 Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic Dermatitis Status COMPLETED Phase PHASE2/PHASE3
NCT01605708 Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis Status TERMINATED Phase PHASE1/PHASE2
NCT01597817 Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01577628 Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis Status TERMINATED Phase NA
NCT01552629 A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients Status COMPLETED Phase PHASE2
NCT01548404 Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01544348 A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL Status COMPLETED Phase PHASE1
NCT01538342 Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis Status COMPLETED Phase NA
NCT01522391 A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 Status COMPLETED Phase PHASE1/PHASE2
NCT01518478 Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot Status COMPLETED Phase EARLY_PHASE1
NCT01475994 Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic Dermatitis Status COMPLETED Phase NA
NCT01471119 Sublingual Immunotherapy in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01469767 Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01467362 Efficacy Emollient on Xerosis in Children With Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT01461941 A Phase 2 Study of E6005 in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2